TNXP Stock Rises on Expanded Medicare Access for Fibromyalgia Drug TONMYA
Tonix secured expanded Medicare coverage for its fibromyalgia drug TONMYA, reaching approximately 9 million additional patients starting January 2027.
/ 1 item
#TNXP↓